Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Wagenaars JA

From Bioblast
Revision as of 14:03, 20 August 2014 by Kandolf Georg (talk | contribs) (Created page with "{{Person |lastname=Wagenaars |firstname=JA }} {{Labelingperson}}")
(diff) ← Older revision | Latest revision (diff) | Newer revision β†’ (diff)
Name Wagenaars JA,
Institution
Address ,
City
State/Province
Country
Email
Weblink
O2k-Network Lab


Labels:



Publications

 PublishedReference
Cheng 2016 Nat Immunol2016Cheng SC, Scicluna BP, Arts RJ, Gresnigt MS, Lachmandas E, Giamarellos-Bourboulis EJ, Kox M, Manjeri GR, Wagenaars JA, Cremer OL, Leentjens J, van der Meer AJ, van de Veerdonk FL, Bonten MJ, Schultz MJ, Willems PH, Pickkers P, Joosten LA, van der Poll T, Netea MG (2016) Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat Immunol 17:406-13.
Grefte 2015 Biochim Biophys Acta2015Grefte S, Wagenaars JA, Jansen R, Willems PH, Koopman WJ (2015) Rotenone inhibits primary murine myotube formation via Raf-1 and ROCK2. Biochim Biophys Acta 1853:1606-14.

Abstracts

 PublishedReference
Grefte 2014 Abstract MiP20142014Myotube formation does not require mitochondrial ATP production but is inhibited by rotenone via the Rho-associated, coiled-coil containing protein kinase II.